FRM
KURA icon

Fox Run Management’s Kura Oncology KURA Stock Holding History

Fox Run Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$543K Buy
49,513
+32,197
+186% +$304K 0.09% 442
2026
Q1 		$134K Buy
+17,316
New +$149K 0.02% 814
2025
Q3 		– Sell
-31,546
Closed -$182K – 1088
2025
Q2 		$182K Buy
31,546
+7,557
+32% +$46.3K 0.03% 764
2025
Q1 		$158K Buy
+23,989
New +$187K 0.02% 825
2024
Q4 		– Sell
-10,831
Closed -$212K – 1034
2024
Q3 		$212K Sell
10,831
-13,509
-56% -$274K 0.05% 660
2024
Q2 		$501K Buy
+24,340
New +$500K 0.09% 403

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Fox Run Management's KURA Position: Q2 2026 in Review

Fox Run Management increased its Kura Oncology (KURA) stake by 186% in Q2 2026, buying an estimated $304K and bringing the position to 49,513 shares worth $543K. The position accounts for 0.09% of the portfolio, ranked #442.

Fox Run Management first reported a position in KURA in Q2 2024 and has held it in 6 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Fox Run Management held 49,513 shares of Kura Oncology worth $543K as of Q2 2026.
  • Fox Run Management bought 32,197 Kura Oncology shares in Q2 2026, an estimated $304K.
  • Kura Oncology made up 0.09% of Fox Run Management's portfolio in Q2 2026, its #442 holding.
  • Fox Run Management first reported a position in Kura Oncology in Q2 2024 and has held it in 6 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.